Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tokiko Watanabe

Showing results (1-10 of 100) with videos related to

Pageof 10
Sort By:
Current Opinion in Virology|September 14, 2015
Influenza virus-host interactomes as a basis for antiviral drug developmentTokiko Watanabe, Yoshihiro Kawaoka
Uirusu|October 31, 2017
Neo-Virology: the raison d'etre of virusesTokiko Watanabe, Yoshihiro Kawaoka
Vaccines|August 26, 2023
Advances in Adjuvanted Influenza VaccinesShintaro Shichinohe, Tokiko Watanabe
Clinical & Translational Immunology|February 27, 2020
Villains or heroes? The raison d'être of virusesTokiko Watanabe, Yoshihiro Kawaoka
Uirusu|May 10, 2017
Control of Ebola hemorrhagic fever: vaccine development and our Ebola project in Sierra LeoneTokiko Watanabe, Yoshihiro Kawaoka
Cell Host & Microbe|June 15, 2010
Cellular networks involved in the influenza virus life cycleTokiko Watanabe, Shinji Watanabe, Yoshihiro Kawaoka
Journal of Virology|March 27, 2009
Influenza A virus lacking M2 protein as a live attenuated vaccineShinji Watanabe, Tokiko Watanabe, Yoshihiro Kawaoka
Npj Viruses|April 28, 2025
Influenza B viruses are more susceptible to high temperatures than influenza A virusesKosuke Takada, Yurie Kida, Shinji Watanabe, et al.
Virology|August 31, 2002
Influenza A virus with defective M2 ion channel activity as a live vaccineTokiko Watanabe, Shinji Watanabe, Hiroshi Kida, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 8, 2003
Selective incorporation of influenza virus RNA segments into virionsYutaka Fujii, Hideo Goto, Tokiko Watanabe, et al.
Pageof 10

Showing results (1-10 of 100) with videos related to

Sort By:
Pageof 10
Current Opinion in Virology|September 14, 2015
Influenza virus-host interactomes as a basis for antiviral drug developmentTokiko Watanabe, Yoshihiro Kawaoka
Uirusu|October 31, 2017
Neo-Virology: the raison d'etre of virusesTokiko Watanabe, Yoshihiro Kawaoka
Vaccines|August 26, 2023
Advances in Adjuvanted Influenza VaccinesShintaro Shichinohe, Tokiko Watanabe
Clinical & Translational Immunology|February 27, 2020
Villains or heroes? The raison d'être of virusesTokiko Watanabe, Yoshihiro Kawaoka
Uirusu|May 10, 2017
Control of Ebola hemorrhagic fever: vaccine development and our Ebola project in Sierra LeoneTokiko Watanabe, Yoshihiro Kawaoka
Cell Host & Microbe|June 15, 2010
Cellular networks involved in the influenza virus life cycleTokiko Watanabe, Shinji Watanabe, Yoshihiro Kawaoka
Journal of Virology|March 27, 2009
Influenza A virus lacking M2 protein as a live attenuated vaccineShinji Watanabe, Tokiko Watanabe, Yoshihiro Kawaoka
Npj Viruses|April 28, 2025
Influenza B viruses are more susceptible to high temperatures than influenza A virusesKosuke Takada, Yurie Kida, Shinji Watanabe, et al.
Virology|August 31, 2002
Influenza A virus with defective M2 ion channel activity as a live vaccineTokiko Watanabe, Shinji Watanabe, Hiroshi Kida, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 8, 2003
Selective incorporation of influenza virus RNA segments into virionsYutaka Fujii, Hideo Goto, Tokiko Watanabe, et al.
Pageof 10